FDA recall D-0719-2022

Olympia Compounding Pharmacy dba Olympia Pharmacy · Class II · drug

Product

NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00

Reason for recall

Product found to be Sub Potent or Exceeded reconstitution time

Distribution

Nationwide in the USA including Puerto Rico.

Key facts

Status: Terminated
Initiation date: 2022-03-08
Report date: 2022-03-30
Termination date: 2023-10-04
Voluntary/Mandated: Voluntary: Firm initiated
Location: Orlando, FL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0719-2022